News
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
10 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
10 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Immuron Announced Travelan Sales Continued Strong Growth
9 Apr 24
Earnings, News, Guidance
12 Health Care Stocks Moving In Thursday's Pre-Market Session
28 Mar 24
Movers
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Monday's Intraday Session
11 Mar 24
Movers
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
11 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
8 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Friday's Intraday Session
8 Mar 24
Movers
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
8 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's After-Market Session
7 Mar 24
Movers
Immuron Announced Travelan Topline Clinical Trial Results Demonstrate Protective Efficacy With Single Daily Dose ; Proceeding To Phase 3 Registration Strategy With FDA
6 Mar 24
News, FDA
Immuron Announced Monday: Travelan Sales YTD Jan 2024 of $2.7M Exceed Peak Full Year FY20 Sales Of $2.5M
13 Feb 24
Earnings, News
Press releases
Immuron to host Live Virtual Event
15 Apr 24
News, Management, Press Releases
Immuron Travelan® sales continued strong growth
10 Apr 24
Press Releases
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
7 Mar 24
Health Care, Press Releases, General
Immuron Presentation Australian Biologics Festival 2024
21 Feb 24
News, Press Releases
Immuron achieves record Travelan® sales
13 Feb 24
Press Releases
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
8 Feb 24
News, Management, Press Releases